Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Charles Salski who wrote (1057)	4/13/1999 12:37:00 AM
From: Mike Roberts	Respond to of 1185

Time to buy? Looks pretty safe at a buck...

To: Charles Salski who wrote (1057)	4/13/1999 1:22:00 AM
From: Intrepid1	Read Replies (1) \| Respond to of 1185

If you really want to wade through a ton of information which will tell you absolutely nothing about the progress of the Hoffman discussions - try here: sedar.com Although the word on the street is the 68 year old Chairman of Hoffman-Ladouche is holding out for a complimentary case of Nortran's experimental erectile drug before he commits to any further funding of the antiarrthmia project. etc.